Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2018   27,391,290      
Beginning Balance at Dec. 31, 2018 $ 22,898 $ 27 $ 115,450 $ (92,564) $ (15)
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   116,997      
Stock-based compensation 1,040   1,040    
Exercise of warrants (in shares)   140,000      
Exercise of warrants 400   400    
Net loss (7,137)     (7,137)  
Foreign currency translation adjustment, net of tax (10)       (10)
Balance (in shares) at Mar. 31, 2019   27,648,287      
Ending Balance at Mar. 31, 2019 $ 17,191 $ 27 116,890 (99,701) (25)
Balance (in shares) at Dec. 31, 2019 33,156,246 33,156,246      
Beginning Balance at Dec. 31, 2019 $ 9,756 $ 33 132,214 (122,492) 1
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   378,051      
Stock-based compensation 1,338   1,338    
Sales of common stock, net of offering costs (in shares)   19,166,667      
Sale of common stock, net of offering costs 26,460 $ 19 26,441    
Net loss (8,005)     (8,005)  
Foreign currency translation adjustment, net of tax $ 9       9
Balance (in shares) at Mar. 31, 2020 52,700,964 52,700,964      
Ending Balance at Mar. 31, 2020 $ 29,558 $ 52 $ 159,993 $ (130,497) $ 10